Cash from Operations (TTM) Chart

Historical Cash from Operations (TTM) Data

View and export this data back to 2009. Start Trial.
Date Value
June 30, 2026 -10.40M
March 31, 2026 -18.73M
December 31, 2025 -19.38M
September 30, 2025 -55.94M
June 30, 2025 -61.22M
March 31, 2025 -55.42M
December 31, 2024 -49.41M
September 30, 2024 -43.98M
June 30, 2024 -47.30M
March 31, 2024 -51.22M
December 31, 2023 -52.64M
September 30, 2023 -36.68M
June 30, 2023 -0.648M
March 31, 2023 13.26M
December 31, 2022 11.28M
September 30, 2022 7.027M
June 30, 2022 -12.90M
March 31, 2022 -19.01M
December 31, 2021 -14.27M
September 30, 2021 -16.42M
June 30, 2021 -19.70M
March 31, 2021 -21.48M
December 31, 2020 -16.46M
September 30, 2020 -18.63M
June 30, 2020 -16.15M
Date Value
March 31, 2020 -11.13M
December 31, 2019 -12.56M
September 30, 2019 -9.619M
June 30, 2019 -9.862M
March 31, 2019 -12.76M
December 31, 2018 -14.09M
September 30, 2018 -5.748M
June 30, 2018 -9.365M
March 31, 2018 -9.374M
December 31, 2017 -8.755M
September 30, 2017 -12.10M
June 30, 2017 -13.58M
March 31, 2017 -5.645M
December 31, 2016 -1.86M
September 30, 2016 -0.904M
June 30, 2016 5.904M
March 31, 2016 1.811M
December 31, 2015 -2.246M
September 30, 2015 -2.508M
June 30, 2015 -1.775M
March 31, 2015 -1.927M
December 31, 2014 -0.494M
September 30, 2014 -9.838M
June 30, 2014 -19.58M
March 31, 2014 -22.38M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

View Cash from Operations (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (TTM) Benchmarks

View Cash from Operations (TTM) Benchmarks
Start Trial
Lifecore Biomedical, Inc. --
Quanterix Corp. -80.92M
Frontage Holdings Corp. 46.81M
Repligen Corp. 134.86M
Bio-Techne Corp. 292.07M